Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women

Clinical trial NCT00358176 · COMPLETED

Trial details

NCT number: NCT00358176
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Osteoporosis Postmenopausal

Start date: 2004-07-01
Primary completion: 2007-03-01
Enrollment: 1231

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.